Today: 9 June 2026
Rolls-Royce (RR.L) share price closes higher on defence bid and buyback update — what to watch next week
17 January 2026
1 min read

Rolls-Royce (RR.L) share price closes higher on defence bid and buyback update — what to watch next week

London, Jan 17, 2026, 07:53 (GMT) — Market closed

  • Rolls-Royce shares closed higher on Friday, holding their position solidly within the UK defence sector.
  • The company revealed an additional tranche of share repurchases as part of its ongoing buyback programme.
  • Coming next: daily buyback disclosures, ongoing geopolitical developments, and the late-February earnings that will reshape forecasts.

Rolls-Royce Holdings (RR.L) ended Friday (Jan. 16) trading 0.98% higher at 1,285.5 pence, with defence shares drawing renewed attention in London as the week wrapped up.

Rolls-Royce now offers a liquid play for investors looking to bet on two fronts: the risks tied to defence spending and the outlook for civil aerospace engine demand. The stock often reacts sharply to shifts in the news cycle.

Rolls-Royce is also acting as a mechanical buyer in the market. The company is conducting a share buyback, repurchasing and canceling its own shares, which trims the number of shares outstanding. This has resulted in a consistent flow of filings.

On Friday, a regulatory filing revealed Rolls-Royce snapped up 460,628 shares on Jan. 15 via UBS, trading on the London Stock Exchange and elsewhere, with plans to cancel them. Since kicking off the buyback programme, the company has repurchased 4,632,900 shares, paying an average of 1,262.5611 pence each.

Defence shares gained ground Friday following Ukrainian President Volodymyr Zelenskiy’s declaration of a state of emergency and the UK’s commitment of £20 million in energy aid to Ukraine. Rolls-Royce climbed 1.1% by mid-morning, while the UK aerospace and defence index rose 1.25%.

Beyond the daily market action, Rolls-Royce’s small modular reactor arm advanced its project storyline. Rolls-Royce SMR has brought Skanska UK on board to build a prototype aseismic bearing pedestal demonstrator. Ruth Todd, operations and supply chain director at Rolls-Royce SMR, said: “Working with Skanska is a significant step forward in proving the capability of our aseismic bearing technology.” World Nuclear News

Stocks that have rerated this sharply can be unforgiving to even minor setbacks. Rolls-Royce’s 52-week peak hits 1,306.50 pence, and its shares carry a headline P/E ratio that looks steep. That leaves little wiggle room if cash flow or guidance disappoints.

As Monday’s session kicks off, traders will be tracking if the defence rally can hold as headlines subside, and whether a wider risk-off sentiment drags down UK cyclicals. Expect a steady stream of buyback announcements hitting inboxes early on.

The next major trigger will be the company’s full-year 2025 results, slated for release on Feb. 26. The interim buyback programme should wrap up by Feb. 24.

Stock Market Today

  • Pro Portfolio Adds Broadcom and Netflix Shares, Upgrades Broadcom Rating
    June 9, 2026, 10:19 AM EDT. The Pro Portfolio is buying 80 shares of Broadcom (AVGO) at around $405, increasing its holdings to 512 shares (3.4% of the portfolio). It is also purchasing 372 shares of Netflix (NFLX) near $82.35, increasing its stake to 2,107 shares (2.85%). Broadcom's AI chip forecast for H2 2026 is viewed as conservative following a $35 billion private credit deal involving Apollo and Blackstone. The rating for Broadcom is upgraded to One, with a checkpoint price of $330 maintained. Netflix's shares are seen as undervalued despite recent declines, supported by a $25 billion buyback and rising U.S. viewership. Netflix's ad business shows growth potential, reaching 250 million monthly active viewers, reinforcing optimism amidst concerns over consumer spending.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Previous Story

Stock Market Today 17.01.2026

IREN stock jumps 11% on analyst upgrade chatter — what matters before Nasdaq reopens
Next Story

IREN stock jumps 11% on analyst upgrade chatter — what matters before Nasdaq reopens

Go toTop